# Contact Peptide Care Now — Editorial Desk

> Reach the Peptide Care Now editorial desk regarding citations, corrections, or research-related correspondence about our Immune & Thymic peptide digest.

Correspondence on citations, corrections, and research-related inquiries — what a data-forward reference desk most wants to hear.

## Editorial correspondence

Peptide Care Now welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory reference that has changed (the FDA drug status of thymosin alpha-1 compounds evolves), or a peer-reviewed study about thymulin or thymosin alpha-1 that should be included on the [references page](/references). Corrections that improve the accuracy of the digest are the most useful messages we receive.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the primary source quickly.

**Editorial mailbox:** editors@peptidecarenow.com

## What this desk cannot do

So that no message goes unanswered for the wrong reason, several things fall outside what this site can address. Peptide Care Now is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or judge whether a particular research finding applies to a particular person.
- Sell, source, recommend, or help locate any compound from any supplier.
- Interpret the 2025 TESTS null result [8] or any other study finding as it relates to an individual's health decisions — that is a conversation for a licensed clinician.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Editorial correspondence is read carefully but responses are not guaranteed and may be delayed; the mailbox is monitored intermittently.

---

A data-forward reading desk for thymic immunology research — effect sizes and study designs, not prescriptions.